{
  "alternativeShortCodes": ["Lp(a)"],
  "displayName": "Lp(a)",
  "longName": "Lipoprotein(a)",
  "unit": "mg/dL",
  "rangeSources": [
    {
      "source": {
        "name": "Peter Attia",
        "url": "https://peterattiamd.com/lpa-and-cvd-risk-clinical-tests-to-measure-lpa/"
      },
      "range": {
        "type": "generic",
        "min": 0,
        "max": 30
      }
    },
    {
      "source": {
        "name": "European Atherosclerosis Society (EAS)",
        "url": "https://academic.oup.com/eurheartj/article/43/39/3925/6670882"
      },
      "range": {
        "type": "generic",
        "min": 0,
        "max": 50
      }
    }
  ],
  "reasonsForHigh": [
    {
      "reason": "Genetics",
      "sources": [
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959873/",
        "https://www.ncbi.nlm.nih.gov/pubmed/20129380"
      ]
    },
    {
      "reason": "Underactive thyroid (hypothyroidism)",
      "sources": [
        "https://www.ncbi.nlm.nih.gov/pubmed/19094068",
        "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972592/",
        "https://www.ncbi.nlm.nih.gov/pubmed/10601541"
      ]
    },
    {
      "reason": "Growth hormones (2x increase with therapy)",
      "sources": ["http://www.ncbi.nlm.nih.gov/pubmed/8427864"]
    },
    {
      "reason": "Pregnancy (2x increase)",
      "sources": ["http://www.ncbi.nlm.nih.gov/pubmed/2937991", "http://www.ncbi.nlm.nih.gov/pubmed/10657577"]
    },
    {
      "reason": "Nephrotic syndrome (3-5 x increase vs. control)",
      "sources": ["http://www.ncbi.nlm.nih.gov/pubmed/14717931", "http://www.ncbi.nlm.nih.gov/pubmed/8264144"]
    },
    {
      "reason": "All other causes",
      "sources": ["https://academic.oup.com/eurheartj/article/43/39/3925/6670882"]
    }
  ],
  "interventionsForHigh": [
    {
      "intervention": "Drugs are still under development",
      "sources": ["https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781646/"]
    },
    {
      "intervention": "Niacin",
      "description": "Flushing form or Niacin, a form of vitamin B3, can decrease Lp(a) by 20-30%.",
      "sources": ["https://www.jacc.org/doi/10.1016/S0735-1097%2823%2903757-9"]
    }
  ]
}
